Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
993.4500 -1.00 (-0.10%)
NSE Oct 10, 2025 15:31 PM
Volume: 1.6M
 

993.45
-0.10%
Karvy
Margins Outperform: Cadila's revenues increased by 29.3% on a YoY basis to Rs 32.5 bn (our estimate of Rs 32.0 bn) during the quarter. Key outperformer was US. Operating margins increased to 27.6% (higher than our estimates of 23.3%) compared to 18.9% in Q4FY17 due to higher revenue, better gross margin and lower R & D.
Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.7
More from Zydus Lifesciences Ltd.
Recommended